AstraZeneca Canada Inc.

AstraZeneca is one of the world’s largest pharmaceutical companies. Backed by a strong research base, extensive packaging and commercial skills, AstraZeneca is focused on turning good ideas into effective medicines that make a difference in important areas of health care.

AstraZeneca’s extensive product portfolio spans over six therapeutic areas including cardiovascular, gastrointestinal, infection, neuroscience, oncology and respiratory. AstraZeneca’s brands include Crestor^®, Nexium^®, Symbicort^®, Iressa^®, Losec^®, Atacand^®, Zoladex^®, Arimidex^®, Pulmicort^®, Zomig^® and Seroquel^®.

AstraZeneca Canada Inc. employs over 1,400 people across Canada. The company’s head office, located in Mississauga, Ontario, houses almost 700 employees working in packaging, administration, clinical research, sales, marketing, and distribution. In addition, more than 125 dedicated and highly skilled scientists work at AstraZeneca’s state-of-the-art basic pain research centre in Montréal, AstraZeneca Research & Development Montréal. Scientists at this high-tech facility are focused on finding new and innovative therapeutic solutions to treat acute and chronic pain.

In Canada, AstraZeneca invests more than Cdn$2 million each week in the pursuit of new therapies. On average, AstraZeneca has one candidate drug entering pre-clinical development each month. The company has a range of exciting prospects in the pipeline, many of which are significant innovations. AstraZeneca’s success in becoming a leader in the pharmaceutical industry has been achieved by outstanding commitment to research. There are 11 research centres in seven countries and over 11,500 people dedicated to discovering breakthrough therapies that improve people’s lives. Worldwide, the company invests over US$3.5 billion per year in research and development.

As part of AstraZeneca’s commitment to improving the health and quality of life for Canadians, AstraZeneca Canada Inc. is dedicated to working with, and contributing to, communities across Canada. At local, national and international levels, AstraZeneca supports a wide range of charitable and educational initiatives. As an Imagine Caring Company, AstraZeneca Canada Inc. commits to donating a minimum of one per cent of pre-tax profits to community organizations. AstraZeneca Canada Inc.’s charitable giving program, Side by Side, encourages, acknowledges, and financially supports employees’ personal involvement and voluntary contributions to different charitable organizations across Canada.

AstraZeneca Canada Inc. also actively supports a wide range of educational programs and health organizations across the country, including the sponsorship of nine research chairs at Canada’s leading universities. The AstraZeneca research chairs provide outstanding training opportunities for talented researchers and scientists at universities and medical institutions across the country.